Holdings
Exome Asset Management LLC
As of Sep 30, 2026, Exome Asset Management LLC reported 51 positions worth US$147M. Largest: Guardant Health, Inc., TG Therapeutics, Inc. and Abivax SA. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Guardant Health, Inc. | 67,500 | US$12M | no change | Sep 30, 2026 |
| TG Therapeutics, Inc. | 188K | US$10.5M | +22,756 | Sep 30, 2026 |
| Abivax SA | 90,919 | US$9M | +44,041 | Sep 30, 2026 |
| Praxis Precision Medicines, Inc. | 29,681 | US$8.64M | +2,476 | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 211K | US$6.74M | no change | Sep 30, 2026 |
| Eli Lilly and Company | 5,492 | US$6.35M | no change | Sep 30, 2026 |
| Natera, Inc. | 13,800 | US$5.7M | no change | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 160K | US$5.15M | +62,280 | Sep 30, 2026 |
| Viking Therapeutics, Inc. | 147K | US$4.81M | +99,636 | Sep 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 107K | US$4.78M | +18,857 | Sep 30, 2026 |